Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 5.36 billion yuan for H1 2025, representing a year-on-year growth of 7.2%, while the net profit attributable to shareholders was 800 million yuan, up 13.8% year-on-year. In Q2 alone, revenue was 3 billion yuan, with a year-on-year increase of 6.5%, and net profit of 410 million yuan, growing 2.4% year-on-year [2][4]. - The company plans to issue H shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and overseas business development, as well as enhance its overseas financing capabilities [2][4]. Financial Performance - In H1 2025, online direct sales, online distribution, and offline sales generated revenues of 3.91 billion, 1.2 billion, and 250 million yuan respectively, with year-on-year changes of 4.9%, 25.9%, and -21.5% [9]. - The main brand and sub-brands showed varied performance, with the main brand's revenue slightly declining by 0.1%, while sub-brands like OR and 原色波塔 saw significant growth of 103% and 80% respectively [9]. - The gross profit margin improved by 3.6 percentage points in H1 2025, attributed to cost reduction and efficiency improvements [9]. - The overall net profit margin increased by 0.9 percentage points to 14.9%, although Q2 saw a slight decline of 0.5 percentage points to 13.6% due to increased sales expenses during promotional periods [9]. Future Outlook - The company is expected to benefit from the ongoing expansion of its main brand and the continued strong performance of its sub-brands, which could contribute to incremental growth [9]. - EPS forecasts for 2025, 2026, and 2027 are projected to be 4.28, 5.05, and 5.77 yuan per share respectively [9].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected stock price increase exceeding 15% compared to the benchmark index [3][10]. Core Insights - The company reported a steady revenue growth of 7.21% year-on-year for the first half of 2025, achieving a total revenue of 5.362 billion yuan. The net profit attributable to the parent company reached 799 million yuan, reflecting a year-on-year increase of 13.8% [1]. - The gross margin improved by 3.56 percentage points to 73.38%, while the net profit margin increased by 0.93 percentage points to 15.41% [1]. - The report highlights the strong performance of the OR brand, which saw a remarkable revenue growth of 102.52% year-on-year, contributing 279 million yuan in revenue [2]. Summary by Sections Financial Performance - For the first half of 2025, the company achieved a revenue of 5.362 billion yuan, with a net profit of 799 million yuan, and a non-recurring net profit of 771 million yuan, marking increases of 7.21%, 13.8%, and 13.49% respectively [1]. - The second quarter alone generated a revenue of 3.003 billion yuan, up 6.49% year-on-year, with a net profit of 408 million yuan, reflecting a growth of 2.36% [1]. Brand Performance - The main brand, Proya, generated 3.979 billion yuan in revenue for the first half of 2025, remaining stable year-on-year. The brand's Tmall flagship store ranked first in the beauty category [2]. - The second brand, Caitang, achieved a revenue of 705 million yuan, representing a year-on-year growth of 21.11% [2]. - The OR brand's revenue reached 279 million yuan, showing a significant increase of 102.52% year-on-year, while the brand Yefuti generated 166 million yuan, up 3.31% [2]. Future Earnings Forecast - The report projects earnings per share (EPS) of 4.49, 5.15, and 5.73 yuan for the years 2025, 2026, and 2027 respectively, with corresponding price-to-earnings (PE) ratios of 20, 18, and 16 times [3].

Core Viewpoint - Despite pressure in the beauty industry, Proya (603605.SH) demonstrates resilience with a revenue of 5.362 billion yuan in the first half of 2025, reflecting a year-on-year growth of 7.21% and a net profit of 799 million yuan, up 13.80% [1] Revenue Performance - Proya's main brand contributed 3.979 billion yuan in revenue, marking a slight decline of 0.08%, the first revenue drop in five years [4] - The main brand had previously shown consistent revenue growth from 2021 to 2024, with growth rates of 31.44%, 43.12%, 35.86%, and 37.67% respectively [4] Brand Portfolio - Proya's brand portfolio includes "Proya," "Caitang," "Off&Relax," "Yuefuti," "CORRECTORS," "INSBAHA," and "Jingshi," covering various beauty segments [3] Growth of Secondary Brands - Secondary brands such as Caitang and Off&Relax continue to show growth, with Caitang generating 705 million yuan in revenue, a year-on-year increase of 21.11% [6][7] - Off&Relax contributed 279 million yuan, with a remarkable growth rate of 102.52% [9] International Expansion Plans - Proya is planning to issue H-shares and list on the Hong Kong Stock Exchange to accelerate its international strategy [2][10] - The appointment of Xue Xia as the new company secretary is aimed at leveraging her extensive capital market experience to facilitate the Hong Kong listing [12][13] Market Positioning - If successful, Proya will become the first domestic beauty company with dual listings (A+H), enhancing its brand image and market reach [11] - The Hong Kong listing is expected to improve Proya's access to global investors and strengthen its presence in the Asia-Pacific market [11]

Summary of the Conference Call Records Industry Overview - The beauty and personal care industry is experiencing an increase in penetration rates and rising prices, showing stronger growth compared to traditional food and beverage sectors, leading new consumption trends [1][7] - Domestic brands are rapidly rising in the beauty and personal care market, replacing foreign brands, particularly Japanese and Korean brands, which are showing significant declines [1][3] Key Financial Performance - **Personal Care Segment**: - 2024 revenue growth of 19% and net profit growth of 25% - Q1 2025 revenue growth of 29% and profit growth of 13%, driven by product innovation and Douyin channel [1][6] - **Medical Aesthetics Segment**: - 2024 revenue growth of 16% and net profit growth of 22% - Q1 2025 revenue and profit remained flat, with significant internal differentiation [1][9] - **Cosmetics Industry**: - 2024 revenue growth of 11% and net profit decline of 9% (11% growth after excluding anomalies) - Some companies like Juzhi Biotechnology and Mao Ge Ping performed exceptionally well [1][10] Channel Performance - Douyin channel is noted for its dual role in marketing and sales, with high initial costs but potential for improved profitability as brand influence expands to other channels [4][8] - In April 2025, beauty brands on Douyin showed strong performance, with several brands achieving over 100% growth [11] Company-Specific Insights - **Ruo Yuchen**: - Q1 2025 revenue and profit growth exceeded 200% for its free brand and over 150% for its household cleaning brand [12] - **Deng Kang Oral Care**: - Q1 2025 revenue and profit growth of 15%-20%, with online channels showing over 200% growth [14] - **Polaire**: - Q1 2025 saw unexpected profit growth due to improved gross margins and optimized sales expenses [16] - **Mao Ge Ping**: - April 2025 Douyin channel growth of over 30% [17] - **Perfect Bio**: - Q1 2025 revenue growth of 28% and net profit close to 30% [18] - **Runben**: - Q1 2025 revenue growth of 44%, with a focus on new product launches [19] Market Trends and Investment Recommendations - The beauty and personal care sector is expected to continue leading new consumption trends, with investment strategies focusing on companies with strong innovation capabilities and those showing positive changes [1][7][26] - Recommended stocks include Ruo Yuchen, Deng Kang Oral Care, and Runben in the personal care segment, and high-end domestic brands like Mao Ge Ping and companies in the collagen segment like Juzhi Biotechnology [26] Additional Insights - The beauty and personal care sector is more sensitive to product demand, innovation, and channel changes compared to other consumer goods, providing a natural premium and innovation potential [24] - The overall market for personal care, beauty, and medical aesthetics is expected to show strong growth, driven by product innovation and structural opportunities [25]